Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Terns Pharmaceuticals

TERN

52.9500.00% ( 0.000 )

Delisted: May 7, 16:00:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Merck Stock Jumps on Phase 3 Cancer Vaccine Win as Keytruda Risk Eases
TradingKey·2 days ago, 09:30 PM
TERN0.00%MRK+2.39%
Key facts: Merck & Co., Inc. Q2 Sales $16.6B; sac-TMT Advances
TradingView·Aug 5 at 02:14 AM
MRK+2.39%
Merck (MRK) Stock Revenue Growth Masks Loss And Margin Compression
Simplywall·Aug 4 at 06:17 PM
TERN0.00%MRK+2.39%
Health Care Down on Mixed Pharma Earnings — Health Care Roundup
MorningStar·Aug 4 at 05:22 PM
- Health-care companies declined as investors rotated into cyclical stocks following mixed earnings reports from major pharmaceutical firms. - Pfizer shares increased after reporting better-than-expected second-quarter earnings driven by rising cancer and heart disease drug sales. - Merck and Novo Nordisk experienced varied stock movements despite differing adjustments to their annual profit and revenue projections.
NVO+1.30%PFE+1.01%
MRK: Q2 2026 sales up 5% to $16.6B, with oncology and new launches driving growth
Quartr·Aug 4 at 05:52 AM
MRK+2.39%
REG - AIM - AIM Notice - 20/07/2026
London Stock Exchange·Jul 20 at 02:00 AM
TERN0.00%
ZAWYA: Dubizzle Group announces strategic partnership and investment in Takeem, UAE-based rental protection platform
Zawya·Jul 7 at 04:02 AM
TERN0.00%
Merck (MRK) Stock After 64% One-Year Rally And Terns Deal Is It Priced Fairly?
Simplywall·Jun 26 at 10:52 AM
MRK+2.39%TERN0.00%